NASDAQ:GENB | Free Cash Flow | Generate Biomedicines, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2025-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$80.39M$3.78M-$84.17M
2025-03-31-$53.18M$751,000.00-$53.93M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income